Stephens Consulting’s Alkermes ALKS Stock Holding History

Stephens Consulting’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20	Closed	-$661	–	1220
2025 Q1	$661	Buy	+20	New	+$652	﹤0.01%	856

Other funds holding ALKS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Stephens Consulting's ALKS Position: Q2 2025 in Review

Stephens Consulting sold out of Alkermes (ALKS) in Q2 2025, closing a stake of 20 shares — an estimated $661 sold.

Stephens Consulting first reported a position in ALKS in Q1 2025 and held it in 1 quarter. The position peaked at $661 in Q1 2025. 353 funds tracked by Wall St. Rank hold ALKS as of Q2 2025.

Stephens Consulting reported no remaining Alkermes position as of Q2 2025 after selling out during the quarter.
Stephens Consulting sold 20 Alkermes shares in Q2 2025, an estimated $661.
Stephens Consulting first reported a position in Alkermes in Q1 2025 and held it in 1 quarter.
Stephens Consulting's Alkermes position peaked at $661 in Q1 2025.
353 funds tracked by Wall St. Rank held Alkermes as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.